A new study from Hong Kong found adults with type 2 diabetes and hypertension who achieved a systolic blood pressure (SBP) of less than 130 mmHg did not experience a reduction in cardiovascular risk, compared to patients with SBPs between 130 and 140 mm Hg. The study’s findings were published in Diabetes Care.

Despite conflicting reports, eating as many as a dozen eggs per week does not increase the cardiovascular risk for individuals with prediabetes or type 2 diabetes, according to a new study in the American Journal of Clinical Nutrition.

A new study published in Pediatrics suggests a low-carbohydrate diet can help people with type 1 diabetes control blood sugar levels with lower-than-normal doses of insulin.

Intensive lipid-lowering therapy significantly reduces all-cause and cardiovascular mortality—but only for patients with low-density lipoprotein cholesterol (LDL-C) levels above 100 mg/dL, according to a meta-analysis published April 17 in JAMA.

Living a healthy lifestyle during adulthood could prolong life expectancy at age 50 by 14 years for women and more than 12 years for men, according to new research published April 30 in the American Heart Association’s Circulation journal.

A healthy diet is a cornerstone to preventing cardiovascular disease, but many healthcare providers receive insufficient nutrition education and training, according to a new scientific advisory released by the American Heart Association.

TITUSVILLE, N.J., April 27, 2018 — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the results of a real-world study showing that adults with type 2 diabetes initiated on INVOKANA® (canagliflozin) 300mg had significantly better blood glucose control, based on A1C goal attainment and reduction, compared to similar patients initiated on Farxiga®(dapagliflozin) 10mg.

A combination of prediabetes and hypertension increases the risk for cardiovascular disease (CVD) more than either risk factor alone, according to new research published April 18 in Hypertension.